0.00Open0.00Pre Close0 Volume0 Open Interest38.00Strike Price0.00Turnover0.00%IV-52.26%PremiumNov 22, 2024Expiry Date13.04Intrinsic Value100Multiplier4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma1.92Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Pfizer Stock Discussion
bottom or not?
more selling
Hugely Undervalued $2 Biotech With 21% Held Short $16 Price Target, Takeover Candidate, Soon Profitable. Fund that owns $Viking Therapeutics (VKTX.US)$ since 2022 below $10 a share is also investing in ESPR and expects the company will be a block buster.
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esper...
No comment yet